X0306 4 2015-03-30 0 0001410939 Ophthotech Corp. OPHT 0001277476 GUYER DAVID R C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119 1 1 0 0 Chief Executive Officer Common Stock 2015-03-30 4 M 0 18582 10.03 A 18582 D Common Stock 2015-03-30 4 S 0 16782 48.19 D 1800 D Common Stock 2015-03-30 4 S 0 1800 48.94 D 0 D Stock Option (Right To Buy) 10.03 2015-03-30 4 M 0 18582 0.00 D 2023-04-25 Common Stock 18582 384650 D The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2013. These shares were disposed of in multiple transactions on March 30, 2015 at actual sales prices ranging from $47.80 to $48.77 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on March 30, 2015 at actual sales prices ranging from $48.80 to $49.27 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017. /s/ Justin Vogel, as Attorney-in-Fact for David Guyer 2015-03-31